![Shannon Soqui](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shannon Soqui
Direttore/Membro del Consiglio presso ACKL SPAC
Posizioni attive di Shannon Soqui
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACKL SPAC | Direttore/Membro del Consiglio | 01/12/2020 | - |
Independent Dir/Board Member | 01/12/2020 | - | |
CMLM Holdings, Inc.
![]() CMLM Holdings, Inc. Specialty StoresRetail Trade CMLM Holdings, Inc. provides hemp-formulated wellness and beauty products. The company is headquartered in Portland, OR. | Presidente | - | - |
Segretario Aziendale | - | - | |
Hempyre Holdings Ltd.
![]() Hempyre Holdings Ltd. Specialty StoresRetail Trade Hempyre Holdings Ltd. engages in the distribution of hemp-formulated consumer packaged goods for beauty, beverage, and wellness industries. The firm focuses on consumer hemp-formulated topical solutions to protect and rejuvenate the skin and body. Its product brands include QIND, Bio-Synergy, Muhu, QINDNESS, ActiVeman, Active Woman, Super7, Bottomley Distillers, Green Origin, Paways, and Wevapers. The company was founded on February 13, 2020 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Next Frontier Brands
![]() Next Frontier Brands Food DistributorsDistribution Services Next Frontier Brands engages in the provision of consumer goods. It offers beverage and hemp-based wellness brands. The company is headquartered in Boulder, CO. | Presidente | - | - |
Fondatore | - | - | |
Direttore/Membro del Consiglio | 01/04/2020 | 20/07/2021 | |
Amministratore Delegato | 01/04/2020 | 20/07/2021 | |
Next Frontier Pharmaceuticals, Inc.
![]() Next Frontier Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Next Frontier Pharmaceuticals, Inc. is a drug developer and provider of cannabinoid and psychedelic APIs. The private company is based in Carrollton, TX. Its wholly owned subsidiary, Benuvia Manufacturing, Inc., owns the FDA-approved cannabinoid drug Syndros® and the largest captive synthetic cannabinoid manufacturing facility. The company's 83,000 square foot manufacturing facility is permitted by the U.S. DEA to manufacture and export Schedule I to III controlled substances and is FDA registered. Next Frontier Pharmaceuticals is pursuing a 505(b)(2) approval pathway with the FDA for six investigational new drugs (INDs). The company also has a robust portfolio of patents and patents pending on organic and synthetic cannabinoids and provides life cycle management services for drug development companies focused on cannabinoids and psychedelics. | Presidente | - | - |
Storia della carriera di Shannon Soqui
Precedenti posizioni note di Shannon Soqui
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ackrell Capital LLC
![]() Ackrell Capital LLC Investment ManagersFinance Ackrell Capital LLC operates as an independent investment bank that focuses on providing financial advisory services. It offers M&A advisory, private placement and corporate development services. The company was founded by Michael Kevin Ackrell and William A. Lamkin in 2003 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2015 | 01/01/2017 |
Formazione di Shannon Soqui
University of California | Undergraduate Degree |
The Santa Clara University School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Chairman | 2 |
Settori
Retail Trade | 3 |
Finance | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
CMLM Holdings, Inc.
![]() CMLM Holdings, Inc. Specialty StoresRetail Trade CMLM Holdings, Inc. provides hemp-formulated wellness and beauty products. The company is headquartered in Portland, OR. | Retail Trade |
Hempyre Holdings Ltd.
![]() Hempyre Holdings Ltd. Specialty StoresRetail Trade Hempyre Holdings Ltd. engages in the distribution of hemp-formulated consumer packaged goods for beauty, beverage, and wellness industries. The firm focuses on consumer hemp-formulated topical solutions to protect and rejuvenate the skin and body. Its product brands include QIND, Bio-Synergy, Muhu, QINDNESS, ActiVeman, Active Woman, Super7, Bottomley Distillers, Green Origin, Paways, and Wevapers. The company was founded on February 13, 2020 and is headquartered in London, the United Kingdom. | Retail Trade |
Next Frontier Brands
![]() Next Frontier Brands Food DistributorsDistribution Services Next Frontier Brands engages in the provision of consumer goods. It offers beverage and hemp-based wellness brands. The company is headquartered in Boulder, CO. | Distribution Services |
Ackrell SPAC Partners I Co.
![]() Ackrell SPAC Partners I Co. Financial ConglomeratesFinance Ackrell SPAC Partners I Co. is a blank check company. It plans to identify and to complete initial business combination in alcoholic and non-alcoholic beverage and wellness sectors of the fast-moving consumer goods market. The company was founded on September 11, 2018 and is headquartered in Claymont, DE. | Finance |
Ackrell Capital LLC
![]() Ackrell Capital LLC Investment ManagersFinance Ackrell Capital LLC operates as an independent investment bank that focuses on providing financial advisory services. It offers M&A advisory, private placement and corporate development services. The company was founded by Michael Kevin Ackrell and William A. Lamkin in 2003 and is headquartered in San Francisco, CA. | Finance |
Next Frontier Pharmaceuticals, Inc.
![]() Next Frontier Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Next Frontier Pharmaceuticals, Inc. is a drug developer and provider of cannabinoid and psychedelic APIs. The private company is based in Carrollton, TX. Its wholly owned subsidiary, Benuvia Manufacturing, Inc., owns the FDA-approved cannabinoid drug Syndros® and the largest captive synthetic cannabinoid manufacturing facility. The company's 83,000 square foot manufacturing facility is permitted by the U.S. DEA to manufacture and export Schedule I to III controlled substances and is FDA registered. Next Frontier Pharmaceuticals is pursuing a 505(b)(2) approval pathway with the FDA for six investigational new drugs (INDs). The company also has a robust portfolio of patents and patents pending on organic and synthetic cannabinoids and provides life cycle management services for drug development companies focused on cannabinoids and psychedelics. | Health Technology |
- Borsa valori
- Insiders
- Shannon Soqui
- Esperienza